May 8, 2018 / 10:48 PM / 4 months ago

BRIEF-Gemphire Therapeutics Reports Q1 Loss Per Share Of $0.58

May 8 (Reuters) - Gemphire Therapeutics Inc:

* GEMPHIRE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 LOSS PER SHARE $0.58

* Q1 EARNINGS PER SHARE VIEW $-0.59 — THOMSON REUTERS I/B/E/S

* TOP-LINE RESULTS FROM INDIGO-1 PHASE 2B TRIAL IN SHTG ARE TARGETED FOR Q2 2018 FOLLOWING COMPLETION OF ENROLLMENT IN Q1 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below